Header Ads

A scary turn in Brazil

Here's the latest news from the global pandemic.

Brazil's worst days are far from over

While most of the world pushes vaccinations and gets back to business, the pandemic has taken a scary turn in Brazil.

It's not surprising that the South American nation, home to 212 million people and rife with income inequality, would have high numbers of infections. Last year it emerged as a global hot spot, ranking second in cases and deaths.

But the savageness of this new wave seems different. Patients are younger, and they are getting sicker. If at last year's peak many still didn't know anyone who had been infected, now every conversation seems to include mention of a friend or relative who's ill, in search of a hospital bed or has died. In March the daily death record was 1,972. Now it's 4,195.

It's been hard to keep track of so many grim milestones reached and then surpassed in such a short span. Every new mark fuels hopes that the ensuing outrage will spark change: Vaccinations will speed up, people will respect social-distancing orders. And yet, not much happens.

Mask-wearing is still by no means the rule, and local news is packed with images of parties. Officials continue to publicly bicker over what to do, and President Jair Bolsonaro hasn't changed his Trump-like stance that the economic toll of lockdowns is worse than the virus.

President Jair Bolsonaro.

Photographer: Andressa Anholete/Bloomberg

There's some good news, though. The government has resumed cash handouts, which should help ease the economic blow, and Brazil recently administered 1 million vaccines a day as pledged by the health ministerthe fourth to occupy the post in a year.

But it's unclear if the progress is sustainable. There's only so much money in government coffers, and expectations of how many doses will be available in the short term keep getting cut. It could be months before Brazil finishes immunizing even priority groups.

So while vaccines remain unavailable to most, the virus keeps spreading, boosted by a low adherence to social distancingeither because of quarantine fatigue or simple economic needand a more contagious variant that emerged in the Amazon rain forest and has since spread.

Fiocruz, a renowned local health institution, said the virus is still "intensely circulating." High rates of contagion mixed with overwhelmed hospitals have caused the mortality rate to jump to 4.2% from 2% in late 2020. All that signals a difficult month ahead for Brazil.—Julia Leite

A key dose

What Went Wrong at AstraZeneca

The story of the vaccine that AstraZeneca developed with the University of Oxford is marked by noble intentions, communication blunders, messy trials, manufacturing nightmares, and political and economic rivalry. Most seriously, the shot is facing a spate of reports that a small number of recipients developed a rare form of blood clotting. In the span of a year, Astra has gone from favored child to problem child in the family of coronavirus vaccines. Read its story here

 A healthcare worker prepares doses of the AstraZeneca vaccine.

Photographer: Antonio Masiello/Getty Images Europe

 

What you should read

Golf Club Membership: Hot Pandemic Investment
In Singapore, prices are hitting record highs as players flock to its courses.
Black Funeral Homes Help New Orleans Grieve
They kept city's unique celebratory traditions alive during first Covid wave.
Nigeria Bets on Solar to Power Its Covid Recovery
Suleiman Babamanu is implementing its largest investment in solar energy.
California Reopens as 'Vacciland' After Lockdown
Most businesses can partially or fully reopen in most populous U.S. state.
Sports-Tied Outbreaks Risk U.S. Schools Opening
Covid is erupting anew in youth sports, a headwind for Biden's school plans.

Know someone else who would like this newsletter? Have them sign up here.

Have any questions, concerns, or news tips on Covid-19 news? Get in touch or help us cover the story.

Like this newsletter? Subscribe for unlimited access to trusted, data-based journalism in 120 countries around the world and gain expert analysis from exclusive daily newsletters, The Bloomberg Open and The Bloomberg Close.

No comments